Comprehensive Analysis of the Rectovaginal Fistula Market: Examining Surgical Advancements and Non-Surgical Treatment Trends
The global market for rectovaginal fistula treatment is experiencing steady growth, driven by rising incidences of contributing factors such as childbirth injuries, Crohn’s disease, and pelvic cancers. A rectovaginal fistula is an abnormal connection between the rectum and the vagina, a condition that significantly impacts a patient's quality of life. Current therapeutic approaches in the Rectovaginal Fistula Market range from medical management to various complex surgical repairs. Non-surgical options primarily involve medications, particularly antibiotics and anti-TNF-α biologics like Infliximab, which have shown particular efficacy in treating fistulas related to Crohn's disease, with maintenance therapy prolonging closure. However, medical therapy is often an adjunct, as surgery remains the definitive treatment. Surgical strategies are diverse, including direct repair, fistulotomy, endorectal or vaginal advancement flaps, and more complex abdominal procedures, with the choice depending heavily on the fistula's location,…
